Variant report
Variant | nsv891282 |
---|---|
Chromosome Location | chr8:111091089-111154532 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:180)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr8:111128379-111128613 | GM12878 | blood: | n/a | n/a |
2 | CEBPB | chr8:111133833-111134173 | A549 | lung: | n/a | chr8:111133993-111134004 |
3 | CEBPB | chr8:111133834-111134178 | MCF-7 | breast: | n/a | chr8:111133993-111134004 |
4 | CEBPB | chr8:111133794-111134166 | HepG2 | liver: | n/a | chr8:111133993-111134004 |
5 | CEBPB | chr8:111149718-111149935 | HepG2 | liver: | n/a | chr8:111149779-111149790 |
6 | CEBPB | chr8:111125982-111126310 | HepG2 | liver: | n/a | chr8:111126145-111126156 chr8:111126143-111126154 |
7 | CEBPB | chr8:111133808-111134191 | HepG2 | liver: | n/a | chr8:111133993-111134004 |
8 | CEBPB | chr8:111130832-111131219 | HepG2 | liver: | n/a | chr8:111131036-111131049 |
9 | CEBPB | chr8:111130860-111131203 | HepG2 | liver: | n/a | chr8:111131036-111131049 |
10 | CEBPB | chr8:111133913-111134088 | H1-hESC | embryonic stem cell: | n/a | chr8:111133993-111134004 |
11 | CEBPB | chr8:111140081-111140301 | HepG2 | liver: | n/a | chr8:111140236-111140247 chr8:111140220-111140231 |
12 | CEBPB | chr8:111128628-111128903 | HepG2 | liver: | n/a | chr8:111128774-111128785 |
13 | CEBPB | chr8:111099313-111099534 | HepG2 | liver: | n/a | chr8:111099383-111099396 chr8:111099326-111099339 chr8:111099326-111099339 chr8:111099328-111099339 chr8:111099385-111099396 chr8:111099383-111099394 chr8:111099328-111099339 |
14 | CEBPB | chr8:111101195-111101518 | HepG2 | liver: | n/a | chr8:111101355-111101368 chr8:111101355-111101366 chr8:111101357-111101366 |
15 | CEBPB | chr8:111128662-111128892 | A549 | lung: | n/a | chr8:111128774-111128785 |
16 | CEBPB | chr8:111140084-111140231 | K562 | blood: | n/a | chr8:111140220-111140231 |
17 | CEBPB | chr8:111101178-111101498 | K562 | blood: | n/a | chr8:111101355-111101368 chr8:111101355-111101366 chr8:111101357-111101366 |
18 | CEBPB | chr8:111133898-111134083 | HepG2 | liver: | n/a | chr8:111133993-111134004 |
19 | CEBPB | chr8:111101196-111101498 | IMR90 | lung: | n/a | chr8:111101355-111101368 chr8:111101355-111101366 chr8:111101357-111101366 |
20 | CEBPB | chr8:111126009-111126224 | K562 | blood: | n/a | chr8:111126145-111126156 chr8:111126143-111126154 |
21 | CEBPB | chr8:111125993-111126265 | A549 | lung: | n/a | chr8:111126145-111126156 chr8:111126143-111126154 |
22 | CEBPB | chr8:111101209-111101497 | A549 | lung: | n/a | chr8:111101355-111101368 chr8:111101355-111101366 chr8:111101357-111101366 |
23 | CEBPB | chr8:111130913-111131088 | HepG2 | liver: | n/a | chr8:111131036-111131049 |
24 | CEBPB | chr8:111133852-111134167 | IMR90 | lung: | n/a | chr8:111133993-111134004 |
25 | CEBPB | chr8:111133935-111134082 | K562 | blood: | n/a | chr8:111133993-111134004 |
26 | CTCF | chr8:111151320-111151470 | HAc | cerebellar: | n/a | n/a |
27 | CTCF | chr8:111151240-111151390 | AG10803 | skin: | n/a | n/a |
28 | CTCF | chr8:111151140-111151290 | SAEC | small airway: | n/a | n/a |
29 | CTCF | chr8:111151140-111151290 | HRPEpiC | eye: | n/a | n/a |
30 | CTCF | chr8:111151202-111151396 | MCF-7 | breast: | n/a | n/a |
31 | CTCF | chr8:111151260-111151328 | GM12878 | blood: | n/a | n/a |
32 | CTCF | chr8:111151180-111151330 | HRPEpiC | eye: | n/a | n/a |
33 | CTCF | chr8:111151260-111151410 | NHEK | skin: | n/a | n/a |
34 | CTCF | chr8:111107202-111107409 | GM12878 | blood: | n/a | n/a |
35 | CTCF | chr8:111151202-111151485 | MCF-7 | breast: | n/a | n/a |
36 | CTCF | chr8:111151220-111151370 | HMEC | breast: | n/a | n/a |
37 | CTCF | chr8:111151196-111151396 | Pancreas_OC | pancreas: | n/a | n/a |
38 | CTCF | chr8:111151152-111151505 | MCF-7 | breast: | n/a | n/a |
39 | CTCF | chr8:111151220-111151370 | HEEpiC | esophagus: | n/a | n/a |
40 | CTCF | chr8:111151220-111151370 | HL-60 | blood: | n/a | n/a |
41 | CTCF | chr8:111151260-111151410 | HEEpiC | esophagus: | n/a | n/a |
42 | CTCF | chr8:111151200-111151350 | BE2_C | brain: | n/a | n/a |
43 | CTCF | chr8:111107220-111107370 | Hela-S3 | cervix: | n/a | n/a |
44 | CTCF | chr8:111151360-111151510 | RPTEC | kidney: | n/a | n/a |
45 | CTCF | chr8:111151260-111151410 | MCF-7 | breast: | n/a | n/a |
46 | CTCF | chr8:111151200-111151350 | AG09319 | gingival: | n/a | n/a |
47 | CTCF | chr8:111151160-111151310 | HRE | kidney: | n/a | n/a |
48 | CTCF | chr8:111151240-111151390 | MCF-7 | breast: | n/a | n/a |
49 | CTCF | chr8:111151120-111151469 | GM12878 | blood: | n/a | n/a |
50 | CTCF | chr8:111151212-111151366 | MCF-7 | breast: | n/a | n/a |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:111147028..111149045-chr8:111188972..111191014,2 | K562 | blood: | |
2 | chr8:111100909..111103732-chr8:111408499..111410564,2 | K562 | blood: | |
3 | chr8:111095057..111097322-chr8:111109649..111112073,2 | K562 | blood: | |
4 | chr14:55367224..55369645-chr8:111125633..111128601,2 | MCF-7 | breast: | |
5 | chr8:111148225..111150967-chr8:111837407..111839836,2 | MCF-7 | breast: | |
6 | chr8:111095057..111097322-chr8:111109649..111112073,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000240590 | TF binding region |
ENSG00000131979 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs374761469 | chr8:111105209-111105210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs555689886 | chr8:111105222-111105223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs565747632 | chr8:111105258-111105259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs533805128 | chr8:111105278-111105279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs62526224 | chr8:111105304-111105305 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs371076269 | chr8:111105336-111105337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs1450746 | chr8:111105342-111105343 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs140122641 | chr8:111105356-111105357 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs188624152 | chr8:111105437-111105438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs541569091 | chr8:111105530-111105531 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs561632453 | chr8:111105598-111105599 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs527304029 | chr8:111105675-111105676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs570034848 | chr8:111105678-111105679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs541053569 | chr8:111105787-111105788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs62526225 | chr8:111105808-111105809 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs181454833 | chr8:111105851-111105852 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs552361695 | chr8:111105856-111105857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs139064077 | chr8:111105885-111105886 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs533497150 | chr8:111105930-111105931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs550347335 | chr8:111105938-111105939 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs570158705 | chr8:111105995-111105996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs556061711 | chr8:111118295-111118296 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs150326552 | chr8:111118296-111118297 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs534342126 | chr8:111121037-111121038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs138224087 | chr8:111121084-111121085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs577924486 | chr8:111121085-111121086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs544930914 | chr8:111121089-111121090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs557176863 | chr8:111121104-111121105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs557334915 | chr8:111121174-111121175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs573785253 | chr8:111121331-111121332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs74853540 | chr8:111121341-111121342 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs190790779 | chr8:111121346-111121347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs573158579 | chr8:111121374-111121375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs545510408 | chr8:111121647-111121648 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs187233507 | chr8:111121839-111121840 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs557115415 | chr8:111121856-111121857 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs573871141 | chr8:111121867-111121868 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs536464612 | chr8:111121882-111121883 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs16880380 | chr8:111121885-111121886 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs138831469 | chr8:111121892-111121893 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs141922508 | chr8:111121924-111121925 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs192032483 | chr8:111121948-111121949 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs549387779 | chr8:111122000-111122001 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs540332593 | chr8:111122016-111122017 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs562040698 | chr8:111125638-111125639 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs527829241 | chr8:111125643-111125644 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs571908884 | chr8:111125726-111125727 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs568900360 | chr8:111125729-111125730 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs148996359 | chr8:111125737-111125738 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs80298214 | chr8:111125747-111125748 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 21611746 | CNVD |
Developmental delay | 21147756 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Breast cancer | 21364760 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:111105200-111106000 | Enhancers | Fetal Intestine Small | intestine |
2 | chr8:111121000-111121400 | Enhancers | Fetal Brain Male | brain |
3 | chr8:111130600-111130800 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr8:111130600-111132800 | Enhancers | Adipose Nuclei | Adipose |
5 | chr8:111130800-111131000 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr8:111130800-111131200 | Enhancers | HepG2 | liver |
7 | chr8:111131000-111132000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr8:111132000-111133400 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr8:111132800-111133600 | Weak transcription | Adipose Nuclei | Adipose |
10 | chr8:111133400-111135400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
11 | chr8:111133600-111134200 | Enhancers | Adipose Nuclei | Adipose |
12 | chr8:111144400-111145800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
13 | chr8:111145000-111145200 | Enhancers | Fetal Brain Male | brain |
14 | chr8:111145000-111145400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
15 | chr8:111145000-111145600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
16 | chr8:111145000-111145600 | Enhancers | Adipose Nuclei | Adipose |
17 | chr8:111145000-111145800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
18 | chr8:111145000-111145800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
19 | chr8:111145000-111145800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
20 | chr8:111145200-111145400 | Enhancers | Fetal Intestine Small | intestine |
21 | chr8:111145200-111145600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
22 | chr8:111145200-111145600 | Enhancers | Fetal Intestine Large | intestine |
23 | chr8:111145600-111147200 | Weak transcription | Fetal Intestine Large | intestine |
24 | chr8:111147200-111148000 | Enhancers | Fetal Intestine Small | intestine |
25 | chr8:111147200-111148600 | Enhancers | Fetal Intestine Large | intestine |
26 | chr8:111148000-111150600 | Weak transcription | Fetal Intestine Small | intestine |
27 | chr8:111150600-111150800 | Enhancers | Fetal Intestine Small | intestine |